Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
24.34
+0.06 (0.25%)
At close: Sep 8, 2026, 4:00 PM EDT
24.37
+0.03 (0.12%)
After-hours: Sep 8, 2026, 7:59 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-63.85-59.5-159.49-225.25-200.19-207.28
Depreciation & Amortization
16.1317.8319.2622.2320.9213.95
Asset Writedown & Restructuring Costs
0.35-7.2125.43--
Loss (Gain) From Sale of Investments
-1.05-2.51-8.21-9.180.747.23
Stock-Based Compensation
49.0251.4853.6162.9155.4843.25
Other Operating Activities
20.794.489.8713.7310.656.93
Change in Accounts Receivable
-5.23-8.65-3.742.03-22.65-7.36
Change in Inventory
-2.11-15.37-2.840.82-5.2
Change in Accounts Payable
0.560.670.67-5.417.113.94
Change in Unearned Revenue
-21.47-36.75-10.48-29.29-56.5-57.73
Change in Other Net Operating Assets
-14.14-12.04-9.28-10.68-0.339.53
Operating Cash Flow
-21.01-45.99-95.21-156.32-183.95-192.73
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-3.03-2.96-3.66-10.7-16.35-61.75
Investment in Securities
-22.2840.9181.46140.3419.25242.96
Investing Cash Flow
-25.337.9577.79129.652.91181.21

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
36.2230.40.242.257.8926.72
Other Financing Activities
-25.6---124.380.43
Financing Cash Flow
173.0330.40.242.25132.2727.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
126.7222.37-17.18-24.43-48.7815.63

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-24.03-48.95-98.88-167.02-200.29-254.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-7.80%-17.67%-55.25%-98.09%-108.09%-164.87%
Free Cash Flow Per Share
-0.15-0.32-0.67-1.16-1.41-1.81
Levered Free Cash Flow
18.980.95-24.48-81.95-90.17-139.1
Unlevered Free Cash Flow
26.178.31-17.24-73.33-87.53-139.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
23.612.648.868.990.49-
Change in Working Capital
-42.39-57.77-17.45-46.18-71.55-56.82
SEC Filings: 10-K · 10-Q